FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Morphine Sulfate Injection

  • U.S. Food and Drug Administration
  • August 31, 2026
  • ID: shortage-morphine-sulfate-injection-hospira-inc-a-pfizer-company-0409-1890-23

Drug Shortage Details

Generic NameMorphine Sulfate Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryAnalgesia/Addiction
Availability StatusLimited Availability
Status (FDA list)Current
NDC Package Code0409-1890-23
Presentation & Dosage Form

Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23)

Manufacturer Contact Info

844-646-4398

Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.
View Official Announcement on FDA.gov

Recent FDA Updates

FDA Safety Alert
Early Alert: Transcatheter Mitral Valve Delivery System Issu...
Oct 15, 2026
Drug Shortage
FDA Drug Shortage: Everolimus Tablet
Oct 14, 2026
FDA Safety Alert
Convenience Kit Recall: AVID Medical Removes Convenience Kit...
Oct 14, 2026
Back to FDA Media Center